Results 231 to 240 of about 1,176,394 (331)
Quantum medicine: A quantum-mechanical framework for redox biology, disease and precision medicine. [PDF]
Sung JY, Cheong JH.
europepmc +1 more source
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin +6 more
wiley +1 more source
Ethnic diversity in precision medicine: a reality or an aspiration? [PDF]
Misra S.
europepmc +1 more source
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe
Kjetil Taskén +24 more
openalex +2 more sources
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu +9 more
wiley +1 more source
Zebrafish Avatars: Toward Functional Precision Medicine in Low-Grade Serous Ovarian Cancer [PDF]
Charlotte Fieuws +10 more
openalex +1 more source
Copy Number Variants and Their Association With Intracerebral Hemorrhage Risk: A Case–Control Study
ABSTRACT Introduction Intracerebral Hemorrhage (ICH) is a leading cause of morbidity and mortality worldwide and lacks effective therapeutic interventions. Despite previous studies, the genetic underpinnings of ICH remain poorly understood. We sought to investigate the role of copy number variants (CNVs) in ICH pathophysiology to identify novel ...
Savvina Prapiadou +12 more
wiley +1 more source
Genomics of ovarian cancers and the potential of precision medicine. [PDF]
Jarratt A +3 more
europepmc +1 more source
Shuta Tomida, Shinichi Toyooka
openaire +2 more sources
Higher Amyloid and Tau Burden Is Associated With Faster Decline on a Digital Cognitive Test
ABSTRACT Objective A 2‐min digital clock‐drawing test (DCTclock) captures more granular features of the clock‐drawing process than the pencil‐and‐paper clock‐drawing test, revealing more subtle deficits at the preclinical stage of Alzheimer's disease (AD). A previous cross‐sectional study demonstrated that worse DCTclock performance was associated with
Jessie Fanglu Fu +16 more
wiley +1 more source

